SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-07-081744
Filing Date
2007-04-16
Accepted
2007-04-16 16:06:10
Documents
7
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 d10ka.htm 10-K/A 350388
2 SUBSIDIARIES OF BIOMARIN PHARMACEUTICAL, INC. dex211.htm EX-21.1 3392
3 CONSENT OF KMPG LLP dex231.htm EX-23.1 2981
4 CONSENT OF PRICEWATERHOUSECOOPERS, LLP dex232.htm EX-23.2 1724
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A)/15D-14(A) dex311.htm EX-31.1 7587
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A)/15D-14(A) dex312.htm EX-31.2 7655
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 3269
  Complete submission text file 0001193125-07-081744.txt   378378
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-26727 | Film No.: 07768311
SIC: 2834 Pharmaceutical Preparations